Oxford University
-
UK startup hopes FDA nod speeds up adoption of VR therapy
The breakthrough device designation for Oxford VR follows a clinical trial that demonstrated the effectiveness of its VR therapy.
-
FDA gives nod to Moderna vaccine for Covid-19
The company’s vaccine is the second approved for emergency use by the FDA. It is expected to pose fewer logistical challenges than the first, which was developed by Pfizer and BioNTech.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Medial EarlySign uses machine learning algorithm to predict who is at risk for certain conditions
Founded in 2009, Medial EarlySign is making use of artificial intelligence technology and EHR data to predict which individuals are at risk for specific health conditions.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
